We have an exciting schedule to offer attendees. Featured sessions this year are:

1. COVID-19’s Effect on Standard Access to Care, and Now Access to Vaccinations
2. The Life Long Care Costs of Sickle Cell Disease on Caregivers and Individuals, focusing on disability and joblessness
3. The Patient Symposium: “A Tale of Two Pandemics,” focusing on the Sickle Cell Disease crisis that was exacerbated with COVID-19.
4. Updates from the recipients of the Access to Excellent Care for Sickle Cell Disease Grant Program, funded by Global Blood Therapeutics. Recipients are from: Augusta University’s Sickle Cell Transition Program, Atrium Health Foundation, East Carolina University, OSF Healthcare Saint Francis Medical Center, and the University of Rochester Medical Center.
5. The Global Status of Sickle Cell Disease Symposium
6. Real World Experience of Biomarkers and New Therapeutics
7. Trauma-Informed Care, including Socioeconomic Status, Family Trauma, and Health Inequities
8. Post-Transplant Care
9. The Clinical Implications of COVID-19 on Sickle Cell Disease
10. Genomics and Gene Therapy
11. Investigational New Drug, Device and Therapeutics Symposium
12. Top Abstract Presentations, Abstract Breakout Sessions and an all-day Poster Session

Abstract and Manuscript submissions for this Symposium are accepted until March 29, 2021.

We are also accepting LATE-BREAKING ABSTRACTS. The deadline is to be announced in the coming weeks.